A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

Markus Cornberg, Homie A. Razavi, Alfredo Alberti, Enos Bernasconi, Maria Buti, Curtis Cooper, Olav Dalgard, John F. Dillion, Robert Flisiak, Xavier Forns, Sona Frankova, Adrian Goldis, Ioannis Goulis, Waldemar Halota, B. Hunyady, Martin Lagging, Angela Largen, Michael Makara, Spilios Manolakopoulos, Patrick Marcellin & 13 others Rui T. Marinho, Stanislas Pol, Thierry Poynard, Massimo Puoti, Olga Sagalova, Scott Sibbel, Krzysztof Simon, Carolyn Wallace, Kendra Young, Cihan Yurdaydin, Eli Zuckerman, Francesco Negro, Stefan Zeuzem

Research output: Contribution to journalArticle

302 Citations (Scopus)

Abstract

Background and Aim: Decisions on public health issues are dependent on reliable epidemiological data. A comprehensive review of the literature was used to gather country-specific data on risk factors, prevalence, number of diagnosed individuals and genotype distribution of the hepatitis C virus (HCV) infection in selected European countries, Canada and Israel. Methodology: Data references were identified through indexed journals and non-indexed sources. In this work, 13000 articles were reviewed and 860 were selected based on their relevance. Results: Differences in prevalence were explained by local and regional variances in transmission routes or different public health measures. The lowest HCV prevalence (≤0.5%) estimates were from northern European countries and the highest (≥3%) were from Romania and rural areas in Greece, Italy and Russia. The main risk for HCV transmission in countries with well-established HCV screening programmes and lower HCV prevalence was injection drug use, which was associated with younger age at the time of infection and a higher infection rate among males. In other regions, contaminated glass syringes and nosocomial infections continue to play an important role in new infections. Immigration from endemic countries was another factor impacting the total number of infections and the genotype distribution. Approximately 70% of cases in Israel, 37% in Germany and 33% in Switzerland were not born in the country. In summary, HCV epidemiology shows a high variability across Europe, Canada and Israel. Conclusion: Despite the eradication of transmission by blood products, HCV infection continues to be one of the leading blood-borne infections in the region.

Original languageEnglish
Pages (from-to)30-60
Number of pages31
JournalLiver International
Volume31
Issue numberSUPPL. 2
DOIs
Publication statusPublished - Jul 2011

Fingerprint

Israel
Hepacivirus
Canada
Epidemiology
Infection
Virus Diseases
Public Health
Genotype
Romania
Russia
Greece
Emigration and Immigration
Syringes
Cross Infection
Switzerland
Italy
Glass
Germany
Injections
Pharmaceutical Preparations

Keywords

  • Diagnosis
  • Epidemiology
  • HCV
  • Hepatitis C
  • Incidence
  • Mortality
  • Prevalence

ASJC Scopus subject areas

  • Hepatology

Cite this

Cornberg, M., Razavi, H. A., Alberti, A., Bernasconi, E., Buti, M., Cooper, C., ... Zeuzem, S. (2011). A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver International, 31(SUPPL. 2), 30-60. https://doi.org/10.1111/j.1478-3231.2011.02539.x

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. / Cornberg, Markus; Razavi, Homie A.; Alberti, Alfredo; Bernasconi, Enos; Buti, Maria; Cooper, Curtis; Dalgard, Olav; Dillion, John F.; Flisiak, Robert; Forns, Xavier; Frankova, Sona; Goldis, Adrian; Goulis, Ioannis; Halota, Waldemar; Hunyady, B.; Lagging, Martin; Largen, Angela; Makara, Michael; Manolakopoulos, Spilios; Marcellin, Patrick; Marinho, Rui T.; Pol, Stanislas; Poynard, Thierry; Puoti, Massimo; Sagalova, Olga; Sibbel, Scott; Simon, Krzysztof; Wallace, Carolyn; Young, Kendra; Yurdaydin, Cihan; Zuckerman, Eli; Negro, Francesco; Zeuzem, Stefan.

In: Liver International, Vol. 31, No. SUPPL. 2, 07.2011, p. 30-60.

Research output: Contribution to journalArticle

Cornberg, M, Razavi, HA, Alberti, A, Bernasconi, E, Buti, M, Cooper, C, Dalgard, O, Dillion, JF, Flisiak, R, Forns, X, Frankova, S, Goldis, A, Goulis, I, Halota, W, Hunyady, B, Lagging, M, Largen, A, Makara, M, Manolakopoulos, S, Marcellin, P, Marinho, RT, Pol, S, Poynard, T, Puoti, M, Sagalova, O, Sibbel, S, Simon, K, Wallace, C, Young, K, Yurdaydin, C, Zuckerman, E, Negro, F & Zeuzem, S 2011, 'A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel', Liver International, vol. 31, no. SUPPL. 2, pp. 30-60. https://doi.org/10.1111/j.1478-3231.2011.02539.x
Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver International. 2011 Jul;31(SUPPL. 2):30-60. https://doi.org/10.1111/j.1478-3231.2011.02539.x
Cornberg, Markus ; Razavi, Homie A. ; Alberti, Alfredo ; Bernasconi, Enos ; Buti, Maria ; Cooper, Curtis ; Dalgard, Olav ; Dillion, John F. ; Flisiak, Robert ; Forns, Xavier ; Frankova, Sona ; Goldis, Adrian ; Goulis, Ioannis ; Halota, Waldemar ; Hunyady, B. ; Lagging, Martin ; Largen, Angela ; Makara, Michael ; Manolakopoulos, Spilios ; Marcellin, Patrick ; Marinho, Rui T. ; Pol, Stanislas ; Poynard, Thierry ; Puoti, Massimo ; Sagalova, Olga ; Sibbel, Scott ; Simon, Krzysztof ; Wallace, Carolyn ; Young, Kendra ; Yurdaydin, Cihan ; Zuckerman, Eli ; Negro, Francesco ; Zeuzem, Stefan. / A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. In: Liver International. 2011 ; Vol. 31, No. SUPPL. 2. pp. 30-60.
@article{1b4ba90a49804f73b7d4f5720f6fac02,
title = "A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel",
abstract = "Background and Aim: Decisions on public health issues are dependent on reliable epidemiological data. A comprehensive review of the literature was used to gather country-specific data on risk factors, prevalence, number of diagnosed individuals and genotype distribution of the hepatitis C virus (HCV) infection in selected European countries, Canada and Israel. Methodology: Data references were identified through indexed journals and non-indexed sources. In this work, 13000 articles were reviewed and 860 were selected based on their relevance. Results: Differences in prevalence were explained by local and regional variances in transmission routes or different public health measures. The lowest HCV prevalence (≤0.5{\%}) estimates were from northern European countries and the highest (≥3{\%}) were from Romania and rural areas in Greece, Italy and Russia. The main risk for HCV transmission in countries with well-established HCV screening programmes and lower HCV prevalence was injection drug use, which was associated with younger age at the time of infection and a higher infection rate among males. In other regions, contaminated glass syringes and nosocomial infections continue to play an important role in new infections. Immigration from endemic countries was another factor impacting the total number of infections and the genotype distribution. Approximately 70{\%} of cases in Israel, 37{\%} in Germany and 33{\%} in Switzerland were not born in the country. In summary, HCV epidemiology shows a high variability across Europe, Canada and Israel. Conclusion: Despite the eradication of transmission by blood products, HCV infection continues to be one of the leading blood-borne infections in the region.",
keywords = "Diagnosis, Epidemiology, HCV, Hepatitis C, Incidence, Mortality, Prevalence",
author = "Markus Cornberg and Razavi, {Homie A.} and Alfredo Alberti and Enos Bernasconi and Maria Buti and Curtis Cooper and Olav Dalgard and Dillion, {John F.} and Robert Flisiak and Xavier Forns and Sona Frankova and Adrian Goldis and Ioannis Goulis and Waldemar Halota and B. Hunyady and Martin Lagging and Angela Largen and Michael Makara and Spilios Manolakopoulos and Patrick Marcellin and Marinho, {Rui T.} and Stanislas Pol and Thierry Poynard and Massimo Puoti and Olga Sagalova and Scott Sibbel and Krzysztof Simon and Carolyn Wallace and Kendra Young and Cihan Yurdaydin and Eli Zuckerman and Francesco Negro and Stefan Zeuzem",
year = "2011",
month = "7",
doi = "10.1111/j.1478-3231.2011.02539.x",
language = "English",
volume = "31",
pages = "30--60",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "SUPPL. 2",

}

TY - JOUR

T1 - A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

AU - Cornberg, Markus

AU - Razavi, Homie A.

AU - Alberti, Alfredo

AU - Bernasconi, Enos

AU - Buti, Maria

AU - Cooper, Curtis

AU - Dalgard, Olav

AU - Dillion, John F.

AU - Flisiak, Robert

AU - Forns, Xavier

AU - Frankova, Sona

AU - Goldis, Adrian

AU - Goulis, Ioannis

AU - Halota, Waldemar

AU - Hunyady, B.

AU - Lagging, Martin

AU - Largen, Angela

AU - Makara, Michael

AU - Manolakopoulos, Spilios

AU - Marcellin, Patrick

AU - Marinho, Rui T.

AU - Pol, Stanislas

AU - Poynard, Thierry

AU - Puoti, Massimo

AU - Sagalova, Olga

AU - Sibbel, Scott

AU - Simon, Krzysztof

AU - Wallace, Carolyn

AU - Young, Kendra

AU - Yurdaydin, Cihan

AU - Zuckerman, Eli

AU - Negro, Francesco

AU - Zeuzem, Stefan

PY - 2011/7

Y1 - 2011/7

N2 - Background and Aim: Decisions on public health issues are dependent on reliable epidemiological data. A comprehensive review of the literature was used to gather country-specific data on risk factors, prevalence, number of diagnosed individuals and genotype distribution of the hepatitis C virus (HCV) infection in selected European countries, Canada and Israel. Methodology: Data references were identified through indexed journals and non-indexed sources. In this work, 13000 articles were reviewed and 860 were selected based on their relevance. Results: Differences in prevalence were explained by local and regional variances in transmission routes or different public health measures. The lowest HCV prevalence (≤0.5%) estimates were from northern European countries and the highest (≥3%) were from Romania and rural areas in Greece, Italy and Russia. The main risk for HCV transmission in countries with well-established HCV screening programmes and lower HCV prevalence was injection drug use, which was associated with younger age at the time of infection and a higher infection rate among males. In other regions, contaminated glass syringes and nosocomial infections continue to play an important role in new infections. Immigration from endemic countries was another factor impacting the total number of infections and the genotype distribution. Approximately 70% of cases in Israel, 37% in Germany and 33% in Switzerland were not born in the country. In summary, HCV epidemiology shows a high variability across Europe, Canada and Israel. Conclusion: Despite the eradication of transmission by blood products, HCV infection continues to be one of the leading blood-borne infections in the region.

AB - Background and Aim: Decisions on public health issues are dependent on reliable epidemiological data. A comprehensive review of the literature was used to gather country-specific data on risk factors, prevalence, number of diagnosed individuals and genotype distribution of the hepatitis C virus (HCV) infection in selected European countries, Canada and Israel. Methodology: Data references were identified through indexed journals and non-indexed sources. In this work, 13000 articles were reviewed and 860 were selected based on their relevance. Results: Differences in prevalence were explained by local and regional variances in transmission routes or different public health measures. The lowest HCV prevalence (≤0.5%) estimates were from northern European countries and the highest (≥3%) were from Romania and rural areas in Greece, Italy and Russia. The main risk for HCV transmission in countries with well-established HCV screening programmes and lower HCV prevalence was injection drug use, which was associated with younger age at the time of infection and a higher infection rate among males. In other regions, contaminated glass syringes and nosocomial infections continue to play an important role in new infections. Immigration from endemic countries was another factor impacting the total number of infections and the genotype distribution. Approximately 70% of cases in Israel, 37% in Germany and 33% in Switzerland were not born in the country. In summary, HCV epidemiology shows a high variability across Europe, Canada and Israel. Conclusion: Despite the eradication of transmission by blood products, HCV infection continues to be one of the leading blood-borne infections in the region.

KW - Diagnosis

KW - Epidemiology

KW - HCV

KW - Hepatitis C

KW - Incidence

KW - Mortality

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=79958748633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958748633&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.2011.02539.x

DO - 10.1111/j.1478-3231.2011.02539.x

M3 - Article

VL - 31

SP - 30

EP - 60

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - SUPPL. 2

ER -